HOME >> BIOLOGY >> NEWS
Encouraging results from validation study of trial of personalized treatment in breast cancer

The overall performance of the gene signature to be used in the first large-scale trial to study the role of such tumor signatures in breast cancer is encouraging and gives the green light to start the trial proper, Dr. Martine Piccart, head of the medical oncology department at the Institut Jules Bordet in Brussels, Belgium, told the San Antonio Breast Cancer conference today (Wednesday 8 December 2004). Dr Piccart heads the TRANSBIG consortium, which intends to use the 70-gene prognostic signature developed by the Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital (NKI-AVL) in MINDACT, a large, prospective, international randomized clinical trial for lymph node negative breast cancer that will look at the utility of the signature in clinical practice.

TRANSBIG is a translational research network involving 39 partners from all over Europe and Latin America. The validation involved centers in France, Sweden, UK and the US and was based on the frozen archival tumor material of 291 node negative (without cancerous cells in the lymph nodes) patients aged < 60, diagnosed through 1998, and who had received only surgery or radiotherapy. The 70-gene signature outperformed existing standard criteria (St. Gallen, Nottingham Prognostic Index, and Adjuvant Online) in predicting time to distant metastasis (the development of tumors in other parts of the body) and overall survival. The statistical analysis was carried out independently of Amsterdam by a statistical team in Belgium, in collaboration with a bioinformatics group in Switzerland. Dr.Piccart said: "While the overall performance of the 70-gene prognostic signature in the external validation series was inferior to the original Amsterdam series, the results are more than good enough to justify starting the trial."

If the trial confirms that the signature is better than standard methods are in determining which women need chemotherapy after their breast cancer has been surgically remo
'"/>

Contact: Nuria Decker
transbig@bordet.be
32-2-541-3526
European Society for Human Reproduction and Embryology
8-Dec-2004


Page: 1 2

Related biology news :

1. Encouraging results of gene therapy for severe combined immunodeficiency
2. Cooperative science program yields results
3. Delayed treatment of childhood-onset bipolar disorder results in negative outcome in adults
4. Smelling for first time results from knowing abnormalities in congenital loss of smell
5. BDSI announces positive phase III clinical trial results
6. Scientists meet to review Envisat results after 5 years of operations
7. Environment and exercise may affect research results, UA study shows
8. Preliminary results of largest scan of autism DNA information
9. Human trial results show excellent safety data, from Geovaxs DNA/MVA AIDS vaccines
10. Rodent sperm work together for better results
11. Dramatic results from combo therapy surprises Krabb-disease researchers

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2020)... (PRWEB) , ... March 03, 2020 , ... Board-certified oral ... Fargo, ND. With over 16 years of training and experience, Dr. Noffze can successfully ... Removing wisdom teeth as soon as possible is beneficial to the oral and overall ...
(Date:2/28/2020)... ... February 28, 2020 , ... Meridian Clinical Research , a leading investigative ... award for Best Clinical Trial Site. Meridian is also the largest member of ... Network award. These nominations were the result of two voting rounds, and winners will ...
(Date:2/28/2020)... ... February 28, 2020 , ... Regen Suppliers is now offering ... available stem cell and exosome biologics. , Regen Suppliers offers an extensive variety ... adipose kits, PDO thread lifts and more. The company is truly a ...
Breaking Biology News(10 mins):
(Date:2/21/2020)... ... February 20, 2020 , ... The dietary ... reassuring consumers that what’s listed on an ingredient panel is actually in their ... this solution with the adoption of CertainT, which is designed to protect the ...
(Date:2/19/2020)... ... February 18, 2020 , ... ... today announced the launch of a new and unified global brand identity, as ... industry’s most complex engineering challenges, as well as an enthusiasm for designing and ...
(Date:2/11/2020)... ... February 11, 2020 , ... Synagro Technologies, Inc. ... today announced that the City of Fort Worth has partnered with Synagro of ... in April of 2020, Synagro will assume operation of the city’s current biosolids ...
(Date:2/3/2020)... ... February 03, 2020 , ... Ovation Travel ... Firm Travel, Technology Industry Travel and Biotech/Healthcare Industry Travel Indexes. , All of ... the following statistics:, Average airfare price paid Domestically, ...
Breaking Biology Technology:
Cached News: